Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25
InChi: InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16
Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy
Basta-Kaim A
11aR)-N-[2
Sirturo fumarate
Sunitinib Malate Size:Solid 2 mg InChi: InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16Sunitinib, also known as SU11248, is the orally bioavailable malate salt of an indolinone based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet derived